About ALDH2

The ALDH2 gene (Aldehyde Dehydrogenase 2) on chromosome 12q24 The E504K variant (rs671) severely reduces ALDH2 activity and is carried by ~40% of East Asian populations, linking to cancer risk. Key targets include Exons 1–13 for comprehensive mutation screening.

Mutations: E504K (rs671), R475W | GC content: 61% | Target exons: Exons 1–13

ALDH2 Primer Design Challenges

  • High GC content (61%): The ALDH2 gene has elevated overall GC content requiring denaturant optimization for robust amplification
  • rs671 hotspot: The common E504K variant in exon 12 falls within primer binding regions requiring careful placement
  • Homologous ALDH genes: ALDH1A1, ALDH1B1 paralogs share 65–70% sequence identity necessitating BLAST-based primer validation

Recommended Primer Design Parameters for ALDH2

ParameterStandard ExonsGC-Rich Regions (≥58%)
Primer length20–22 nt22–25 nt
GC content45–55%50–60%
Tm58–62°C60–65°C
Amplicon size150–300 bp180–350 bp
Annealing temp58–60°C60–64°C (touchdown)
PCR additiveStandardAdd 5–10% DMSO or betaine

Recommended Primer Sequences for ALDH2

Target RegionForward Primer (5′→3′)Reverse Primer (5′→3′)Amplicon
Exon 2 (active site)5′-GTGGAGACCCATTCATCGGT-3′5′-AGCTGGTACTCAGCATCGTG-3′185 bp
Exon 12 (rs671 region)5′-CACTGCTGATGACAGGGCTG-3′5′-CAACCTCCCATCAGCATGAG-3′199 bp

Key SNPs to Avoid in Primer Binding Sites

When designing ALDH2 primers, avoid these clinically significant variants:

  • rs671 (E504K) — Exon 12 variant affecting enzyme activity
  • rs2228093 (R475W) — Exon 11 polymorphism in catalytic domain

Clinical Validation Required
All ALDH2 primers designed with VigyanLLM are for research use only. Clinical diagnostic applications require additional wet-lab validation, Sanger sequencing confirmation, and regulatory approval before patient use.

Design ALDH2 Primers Now

Pre-configured with ALDH2-specific parameters. Use our primer design, Tm calculator, and GC content tools for optimal results.

Design ALDH2 Primers → Tm Calculator GC Calculator